INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,933 | +2584.6% | 320 | +1500.0% | 0.00% | – |
| Q2 2023 | $221 | -77.8% | 20 | -73.0% | 0.00% | – |
| Q1 2023 | $994 | +302.4% | 74 | +270.0% | 0.00% | – |
| Q4 2022 | $247 | – | 20 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 20 | -77.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 87 | -27.5% | 0.00% | – |
| Q1 2022 | $2,000 | – | 120 | +500.0% | 0.00% | – |
| Q4 2021 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 20 | -85.2% | 0.00% | – |
| Q1 2021 | $3,000 | – | 135 | +575.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 20 | -85.6% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 139 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +600.0% | 139 | +595.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 20 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 20 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -93.3% | 20 | -89.2% | 0.00% | – |
| Q2 2019 | $15,000 | +275.0% | 186 | +353.7% | 0.00% | – |
| Q1 2019 | $4,000 | -77.8% | 41 | -77.5% | 0.00% | – |
| Q4 2018 | $18,000 | +260.0% | 182 | +451.5% | 0.00% | – |
| Q3 2018 | $5,000 | -50.0% | 33 | -72.5% | 0.00% | – |
| Q2 2018 | $10,000 | +100.0% | 120 | +37.9% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 87 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 87 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |